Cargando…
First-in-human clinical trials with vaccines—what regulators want
Several factors should be taken into account when it comes to the first exposure of humans to a novel vaccine.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096781/ https://www.ncbi.nlm.nih.gov/pubmed/20829825 http://dx.doi.org/10.1038/nbt0910-910 |
| _version_ | 1783510910034247680 |
|---|---|
| author | Goetz, Karen B Pfleiderer, Michael Schneider, Christian K |
| author_facet | Goetz, Karen B Pfleiderer, Michael Schneider, Christian K |
| author_sort | Goetz, Karen B |
| collection | PubMed |
| description | Several factors should be taken into account when it comes to the first exposure of humans to a novel vaccine. |
| format | Online Article Text |
| id | pubmed-7096781 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70967812020-03-26 First-in-human clinical trials with vaccines—what regulators want Goetz, Karen B Pfleiderer, Michael Schneider, Christian K Nat Biotechnol Article Several factors should be taken into account when it comes to the first exposure of humans to a novel vaccine. Nature Publishing Group US 2010 /pmc/articles/PMC7096781/ /pubmed/20829825 http://dx.doi.org/10.1038/nbt0910-910 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2010 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Article Goetz, Karen B Pfleiderer, Michael Schneider, Christian K First-in-human clinical trials with vaccines—what regulators want |
| title | First-in-human clinical trials with vaccines—what regulators want |
| title_full | First-in-human clinical trials with vaccines—what regulators want |
| title_fullStr | First-in-human clinical trials with vaccines—what regulators want |
| title_full_unstemmed | First-in-human clinical trials with vaccines—what regulators want |
| title_short | First-in-human clinical trials with vaccines—what regulators want |
| title_sort | first-in-human clinical trials with vaccines—what regulators want |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096781/ https://www.ncbi.nlm.nih.gov/pubmed/20829825 http://dx.doi.org/10.1038/nbt0910-910 |
| work_keys_str_mv | AT goetzkarenb firstinhumanclinicaltrialswithvaccineswhatregulatorswant AT pfleiderermichael firstinhumanclinicaltrialswithvaccineswhatregulatorswant AT schneiderchristiank firstinhumanclinicaltrialswithvaccineswhatregulatorswant |